ABTNYSEPharmaceutical PreparationsFiscal year ends December 31

ABBOTT LABORATORIES

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 28, 2026

$104.06−0.83 (-0.79%)

Close on Oct 19, 2026

Community

Notes and questions about Abbott Laboratories from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Abbott Laboratories's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jun 1, 1998
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ABT.

Revenue growth6.6% · median 9.2%

Gross margin56.3% · median 69.7%

Operating margin17.1% · median 12.8%

Net margin13.9% · median 21.5%

Advertisement
300 × 250